http://www.inboxrobot.com/news/alimtaConstantly updated news and information about a variety of topics. http://www.inboxrobot.com/news.php?fid=192325905 9 Oct 2008 20:41 GMT ... NEW YORK - The drugmaker Eli Lilly & Co. said Monday it ... that would expand its pipeline of cancer treatments. New York-based ImClone had previously rejected as ... cancers, the lung cancer and mesothelioma treatment Alimta, and chemotherapy agent Gemzar. The company identified ... http://www.inboxrobot.com/news.php?fid=192153841 9 Oct 2008 05:54 GMT ... will add Erbitux to its small-molecule cancer drugs, Alimta and Gemzar, and enhance its pipeline in ... of the leading oncology franchises in the biopharmaceutical industry," Lilly CEO John C. Lechleiter told ... http://www.inboxrobot.com/news.php?fid=191988087 8 Oct 2008 01:32 GMT ... decent pipeline -- it has 13 oncology drugs in development, not to mention its other ... of potentially complementing its existing oncology drugs, Alimta and Gemzar. The company may be able ... sold next. Do you hear footsteps, Amylin Pharmaceuticals and Biogen Idec Want to make money ... http://www.inboxrobot.com/news.php?fid=191979722 8 Oct 2008 00:57 GMT ... NCI Studying Biomarker Use in Lung Cancer Treatment. WASHINGTON -- The National Cancer Institute (NCI) ... Institute (NCI) has launched a 1,200-patient clinical trial to test whether biomarkers can be used ... (erlotinib) and Indianapolis-based Eli Lilly and Co.'s Alimta (pemetrexed) in patients with non-small-cell lung cancer ... http://www.inboxrobot.com/news.php?fid=191975560 8 Oct 2008 00:31 GMT ... for and a failed courtship of the biotech by and ImClone announced Oct. 6 that ... patent expirations. Lilly currently markets two oncology drugs: Alimta, which generated $854 million in 2007 sales, ...